Brind.

Curis is seeking accelerated submissions in Europe for its work on BTK inhibitors, specifically regarding the Taga lymphoma study.

1 report, 1 independent Updated Aug 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Curis (United States)Europe

Keep exploring

The entities involved

Curis (United States)
company in Lexington, United States

Nothing else this week.
Europe
terrestrial continent located in north-western Eurasia
- The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49

Coverage

Newest first; wire copies grouped

Aug 6GuruFocus.comCuris Inc (CRIS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the ful